Cryo-Cell International, Inc. CCEL
CCEL
Cryo-Cell International, Inc. ZYXI
Zynex, Inc. JSPR
Jasper Therapeutics, Inc. NMTC
NeuroOne Medical Technologies Corporation YI
111, Inc. PIII
P3 Health Partners Inc. MURA
Mural Oncology plc ATHE
Alterity Therapeutics Limited EVAX
Evaxion Biotech A/S LIMN
Liminatus Pharma, Inc. Class A Common Stock
Cryo-Cell International, Inc. ZYXI
Zynex, Inc. JSPR
Jasper Therapeutics, Inc. NMTC
NeuroOne Medical Technologies Corporation YI
111, Inc. PIII
P3 Health Partners Inc. MURA
Mural Oncology plc ATHE
Alterity Therapeutics Limited EVAX
Evaxion Biotech A/S LIMN
Liminatus Pharma, Inc. Class A Common Stock
Performance
| Periode | CCEL | ZYXI | JSPR | NMTC | YI | PIII | MURA | ATHE | EVAX | LIMN |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -28.87 % | -96.70 % | -54.33 % | 24.78 % | -25.07 % | -50.77 % | -19.05 % | -25.16 % | 73.00 % | -85.76 % |
| YTD | 0.58 % | -30.56 % | -16.85 % | 5.93 % | 104.71 % | -8.57 % | 0.00 % | 9.18 % | -3.40 % | 20.04 % |
| 1Y | -53.38 % | -99.05 % | -71.35 % | -13.19 % | 31.70 % | -70.37 % | -44.11 % | 0.88 % | 35.42 % | -84.65 % |
| 3Y | -20.14 % | -99.55 % | -91.99 % | -25.39 % | -81.29 % | -96.19 % | -46.32 % | -19.58 % | -94.22 % | -84.65 % |
| 5Y | -57.14 % | -99.54 % | -98.51 % | -83.28 % | -92.26 % | -99.34 % | -46.32 % | -79.22 % | -99.08 % | -84.65 % |
| 10Y | 10.93 % | -79.66 % | -98.44 % | -92.51 % | -95.91 % | -99.34 % | -46.32 % | -88.50 % | -99.08 % | -84.65 % |
| From the beginning | -31.00 % | -92.57 % | -98.44 % | -92.51 % | -95.91 % | -99.34 % | -46.32 % | -99.49 % | -99.08 % | -84.65 % |